Literature DB >> 2817944

Cows' milk sensitive enteropathy in cystic fibrosis.

S M Hill1, A D Phillips, M Mearns, J A Walker-Smith.   

Abstract

Proximal small intestinal mucosal biopsies were carried out in children with cystic fibrosis who had diarrhoea and failed to thrive in spite of adequate treatment, including pancreatic supplements. Histological examination of eight of the 17 biopsies taken over a period of 12 years showed evidence of enteropathy, and accounted for one in 13 (8%) children with cystic fibrosis under 3 years of age attending our clinic. Seven responded to a cows' milk free diet; the diarrhoea stopped and weight gain increased. One of these responded only when gluten was also excluded from his diet. The eighth child remained on a normal diet and his symptoms did not improve. The enteropathy had resolved in all five patients who had further biopsies taken while receiving treatment, and from 15 months to 3 years of age all the children tolerated a normal diet and continued to thrive. Cows' milk sensitive enteropathy is an important cause of failure to thrive in children with cystic fibrosis. Small intestinal biopsy is an important investigation in younger children who fail to thrive and have diarrhoea despite adequate treatment.

Entities:  

Mesh:

Year:  1989        PMID: 2817944      PMCID: PMC1792745          DOI: 10.1136/adc.64.9.1251

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  17 in total

1.  DISACCHARIDE INTOLERANCE AND MUCOVISCIDOSIS.

Authors:  R H JONES
Journal:  Lancet       Date:  1964-07-18       Impact factor: 79.321

2.  Development of childhood allergy in infants fed breast, soy, or cow milk.

Authors:  S R Halpern; W A Sellars; R B Johnson; D W Anderson; S Saperstein; J S Reisch
Journal:  J Allergy Clin Immunol       Date:  1973-03       Impact factor: 10.793

3.  Cystic fibrosis and coeliac disease. Report of two cases.

Authors:  G Sokol; B Taylor
Journal:  Arch Dis Child       Date:  1973-09       Impact factor: 3.791

4.  Disaccharides and cystic fibrosis of the pancreas.

Authors:  I S Gibbons
Journal:  Arch Dis Child       Date:  1969-02       Impact factor: 3.791

5.  Microvillous surface area in secondary disaccharidase deficiency.

Authors:  A D Phillips; S Avigad; J Sacks; S J Rice; N E France; J A Walker-Smith
Journal:  Gut       Date:  1980-01       Impact factor: 23.059

6.  Disaccharidase activities of duodenal mucosa in children. (Normal subjects, coeliac DISEASE, malnutrition, cystic fibrosis of pancreas, other chronic enteropathies).

Authors:  S Nordio; G M Lamedica; A Berio; L Vignolo
Journal:  Ann Paediatr       Date:  1966

7.  Enteropathy related to fish, rice, and chicken.

Authors:  J C Vitoria; C Camarero; A Sojo; A Ruiz; J Rodriguez-Soriano
Journal:  Arch Dis Child       Date:  1982-01       Impact factor: 3.791

8.  Disaccharidase activities in small intestinal mucosa in patients with cystic fibrosis.

Authors:  I Antonowicz; E Lebenthal; H Shwachman
Journal:  J Pediatr       Date:  1978-02       Impact factor: 4.406

9.  Quantitative analysis of small intestinal mucosa in cow's milk-sensitive enteropathy.

Authors:  C Maluenda; A D Phillips; A Briddon; J A Walker-Smith
Journal:  J Pediatr Gastroenterol Nutr       Date:  1984-06       Impact factor: 2.839

10.  Improved growth and clinical, nutritional, and respiratory changes in response to nutritional therapy in cystic fibrosis.

Authors:  R Shepherd; W G Cooksley; W D Cooke
Journal:  J Pediatr       Date:  1980-09       Impact factor: 4.406

View more
  3 in total

Review 1.  Control of malabsorption in cystic fibrosis.

Authors:  J M Littlewood; S P Wolfe
Journal:  Paediatr Drugs       Date:  2000 May-Jun       Impact factor: 3.022

Review 2.  Gastrointestinal complications in cystic fibrosis.

Authors:  J M Littlewood
Journal:  J R Soc Med       Date:  1992       Impact factor: 5.344

Review 3.  Abdominal pain in cystic fibrosis.

Authors:  J M Littlewood
Journal:  J R Soc Med       Date:  1995       Impact factor: 5.344

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.